Zydus Wellness reported a consolidated net profit of ₹1,189 million for Q1FY26, down from ₹1,279 million in the same period last year. Despite a significant year-on-year rise in revenue from operations to ₹14,370 million from ₹8,609 million, the decline in net profit reflects increased operational costs and higher tax expenses. On the operating front, EBITDA rose sharply to ₹2.42 billion from ₹1.56 billion year-on-year, though the EBITDA margin contracted to 16.82% from 18.10% over the same period.

Q1FY26 Financial Performance

The Board of Directors approved the unaudited financial results on August 4, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and limited reviewed by Mukesh M. Shah & Co., the statutory auditors. The following table summarises the key consolidated financial metrics for the quarter:

Revenue from operations surged due to the inclusion of Comfort Click Limited (CCL), acquired in August 2025, and the consolidation of Naturell (India) Private Limited (NIPL) business effective September 20, 2025. However, total expenses rose sharply to ₹12,787 million from ₹7,186 million, driven by higher advertisement and promotion expenses (₹2,612 million vs ₹1,325 million) and other expenses (₹3,435 million vs ₹1,171 million). While absolute EBITDA expanded meaningfully on the back of higher revenues, the margin compression reflects the proportionally higher cost base introduced through these acquisitions.

Key Operational Developments

The company's segment remains "Consumer Products." The acquisition of CCL by subsidiary Alidac UK Limited for GBP 239 million plus a profit-ticker payment of GBP 2.64 million has significantly expanded the group's footprint. The results include CCL's operations from August 29, 2025, with provisional purchase price allocation figures. Additionally, the voluntary liquidation of NIPL was completed, with its business undertaking distributed to Zydus Wellness on a going concern basis.

Tax and Exceptional Items

Total tax expense increased to ₹432 million from ₹174 million in Q1FY25. This includes a reversal of Minimum Alternate Tax (MAT) credit entitlement of Nil for Q1FY26, compared to ₹146 million in Q1FY25. There were no exceptional items in Q1FY26, whereas FY25 saw exceptional expenses related to NIPL liquidation and CCL acquisition totalling ₹408 million.

Standalone Results

On a standalone basis, Zydus Wellness posted a net profit of ₹55 million for Q1FY26, up from ₹46 million in Q1FY25. Standalone revenue from operations was ₹1,530 million, compared to ₹1,409 million in the previous year. The standalone profit before tax was ₹74 million, slightly lower than ₹79 million in Q1FY25.

Zydus Wellness has scheduled an analyst and institutional investor conference call on August 4, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026. The interaction will provide insights into the company's performance for Q1FY27, with leadership addressing queries from the investment community.

The teleconference is set to commence at 15:00 hrs IST. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management Representation

The proceedings will be led by key executives from zydus wellness :

• Mr. Tarun Arora, CEO
• Mr. Umesh Parikh, CFO

Conference Call Details

Participants can join the discussion via the following universal access numbers:

International attendees have the option to dial in via toll-free numbers specific to their region:

A Diamond Pass registration link is available for interested participants. ICICI Securities is coordinating the event.